| Radiomics, tumor volume, and blood biomarkers for early prediction of pseudoprogression in patients with metastatic melanoma treated with immune checkpoint inhibition L Basler, HS Gabryś, SA Hogan, M Pavic, M Bogowicz, D Vuong, ... Clinical Cancer Research 26 (16), 4414-4425, 2020 | 92 | 2020 |
| SBRT for oligoprogressive oncogene addicted NSCLC L Basler, SGC Kroeze, M Guckenberger Lung cancer 106, 50-57, 2017 | 58 | 2017 |
| Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning study L Basler, N Andratschke, S Ehrbar, M Guckenberger, S Tanadini-Lang Radiation Oncology 13, 1-8, 2018 | 44 | 2018 |
| A tumor-immune interaction model for hepatocellular carcinoma based on measured lymphocyte counts in patients undergoing radiotherapy W Sung, C Grassberger, AL McNamara, L Basler, S Ehrbar, ... Radiotherapy and Oncology 151, 73-81, 2020 | 33 | 2020 |
| Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries SGC Kroeze, C Fritz, L Basler, E Gkika, TB Brunner, AL Grosu, ... Strahlentherapie und Onkologie 195 (3), 199-206, 2019 | 24 | 2019 |
| Targeting treatment resistance in head and neck squamous cell carcinoma–proof of concept for CT radiomics-based identification of resistant sub-volumes M Bogowicz, M Pavic, O Riesterer, T Finazzi, H Garcia Schüler, ... Frontiers in Oncology 11, 664304, 2021 | 18 | 2021 |
| Prediction of early response to immune checkpoint inhibition using FDG-PET/CT in melanoma patients K Kudura, F Dimitriou, L Basler, R Förster, D Mihic-Probst, T Kutzker, ... Cancers 13 (15), 3830, 2021 | 17 | 2021 |
| Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy L Basler, R Poel, C Schröder, A Bolsi, A Lomax, S Tanadini-Lang, ... Radiation oncology 15, 1-10, 2020 | 17 | 2020 |
| Abscopal effects of radiotherapy and combined mRNA-based immunotherapy in a syngeneic, OVA-expressing thymoma mouse model L Basler, A Kowalczyk, R Heidenreich, M Fotin-Mleczek, S Tsitsekidis, ... Cancer Immunology, Immunotherapy 67, 653-662, 2018 | 17 | 2018 |
| Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging C Oliveira, F Amstutz, D Vuong, M Bogowicz, M Hüllner, R Foerster, ... EJNMMI research 11 (1), 79, 2021 | 15 | 2021 |
| Sex-related differences in metastatic melanoma patients treated with immune checkpoint inhibition K Kudura, L Basler, L Nussbaumer, R Foerster Cancers 14 (20), 5145, 2022 | 12 | 2022 |
| Impact of low-dose irradiation of the lung and heart on toxicity and pulmonary function parameters after thoracic radiotherapy C Schröder, A Buchali, P Windisch, E Vu, L Basler, DR Zwahlen, R Förster Cancers 13 (1), 22, 2020 | 11 | 2020 |
| Inflammatory blood parameters as biomarkers for response to immune checkpoint inhibition in metastatic melanoma patients K Kudura, L Nussbaumer, R Foerster, L Basler Biomedicines 10 (9), 2135, 2022 | 5 | 2022 |
| NTCP modeling for high-grade temporal radionecroses in a large cohort of patients receiving pencil beam scanning proton therapy for skull base and head and neck tumors C Schröder, A Köthe, C De Angelis, L Basler, G Fattori, S Safai, D Leiser, ... International Journal of Radiation Oncology* Biology* Physics 113 (2), 448-455, 2022 | 5 | 2022 |
| Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients K Kudura, F Dimitriou, D Mihic-Probst, UJ Muehlematter, T Kutzker, ... Diagnostics 11 (5), 883, 2021 | 5 | 2021 |
| PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors HS Gabryś, L Basler, S Burgermeister, S Hogan, M Ahmadsei, M Pavic, ... Frontiers in Oncology 12, 977822, 2022 | 4 | 2022 |
| Improved survival prediction by combining radiological imaging and S-100B levels into a multivariate model in metastatic melanoma patients treated with immune checkpoint inhibition S Burgermeister, HS Gabryś, L Basler, SA Hogan, M Pavic, M Bogowicz, ... Frontiers in Oncology 12, 830627, 2022 | 4 | 2022 |
| Sex-Related Differences in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition. Cancers 2022, 14, 5145 K Kudura, L Basler, L Nussbaumer, R Foerster s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 2 | 2022 |
| NTCP Modelling for High Grade Temporal Radio-Necrosis in a Large Cohort of Patients Receiving PBS Proton Therapy for Skull Base and Head and Neck Tumors C Schroeder, A Köthe, C De Angelis, L Basler, D Leiser, A Lomax, ... International Journal of Radiation Oncology* Biology* Physics 111 (3), e586-e587, 2021 | 1 | 2021 |
| CT radiomics differentiates levels of radiocurability in tumor subvolumes in head and neck cancer M Bogowicz, M Pavic, O Riesterer, T Finazzi, HG Schüler, E Holz-Sapra, ... training 56, 28, 2020 | 1 | 2020 |
